Recruiting
Lung transplant+1
RecruitingInvestigationalNo placebo
Study on the Safety of Allogeneic Mesenchymal Stromal Cells for Patients with Chronic Lung Transplant Rejection
InvestigationalNo placebo
- Disease:Lung transplantLung transplant rejection
- Substances:Allogeneic Bone Marrow-Derived Mesenchymal Adult Stromal Cells, Ex-Vivo Expanded
Countries:
Spain
Spain- Participants:18–64 years
- Substances:Allogeneic Bone Marrow-Derived Mesenchymal Adult Stromal Cells, Ex-Vivo Expanded
- Sponsor:Fundacion Para La Investigacion Biomedica Del Hospital Universitario Puerta De Hierro Majadahonda






